Pancreatic Cancer Research

ResearcherDuke UniversityActive in the last 2 years

Dan German Blazer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7261-9254; OpenAlex author ID A5080553084. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
43
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 11

  1. Social Vulnerability as a Neighborhood-Level Determinant of Pancreatic Cancer Survivorship: A National Analysis of Veterans Affairs Patients. Co-author DOI 10.1245/s10434-025-18232-6↗
  2. A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. Co-author DOI 10.1007/s00262-025-04146-5↗
  3. Genome-based classification of pancreatic acinar cell carcinoma reveals similarities to KRAS wild-type PDAC. Co-author DOI 10.1186/s12967-025-07381-7↗
  4. Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy. Co-author DOI 10.1245/s10434-023-13318-5↗
  5. Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node … Co-author DOI 10.1007/s00423-020-01859-2↗
  6. Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2020.03.006↗
  7. Nationwide trends and outcomes associated with neoadjuvant therapy in pancreatic cancer: An analysis of 18 243 patients. Co-author DOI 10.1002/jso.24630↗
  8. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers. Last author DOI 10.1097/sla.0000000000001924↗
  9. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma. Last author DOI 10.1245/s10434-015-4937-x↗
  10. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? Co-author DOI 10.1002/jso.23044↗
  11. Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. Co-author DOI 10.1111/j.1532-5415.2011.03785.x↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel P. Nussbaum · 7 shared papers, 2016–2026 · strength 1.02
  2. Michael E. Lidsky · 5 shared papers, 2017–2026 · strength 0.97
  3. Sabino Zani · 4 shared papers, 2020–2025 · strength 0.71
  4. Peter J. Allen · 3 shared papers, 2023–2026 · strength 0.69
  5. Sabran J. Masoud · 2 shared papers, 2020–2026 · strength 0.42
  6. Austin M. Eckhoff · 2 shared papers, 2023–2025 · strength 0.39
  7. Elishama N. Kanu · 2 shared papers, 2023–2025 · strength 0.39
  8. Mohamed A. Adam · 4 shared papers, 2016–2020 · strength 0.34
  9. Allison N. Martin · 1 shared paper, 2026 · strength 0.30
  10. Vinod P. Balachandran · 1 shared paper, 2025 · strength 0.20
  11. Julia Button · 1 shared paper, 2025 · strength 0.20
  12. Mengyuan Liu · 1 shared paper, 2025 · strength 0.20
  13. Kevin C. Soares · 1 shared paper, 2025 · strength 0.20
  14. Michael Ian D'Angelica · 1 shared paper, 2025 · strength 0.20
  15. Tao Wang · 1 shared paper, 2025 · strength 0.20
  16. Erika J. Crosby · 1 shared paper, 2025 · strength 0.20
  17. Jeffrey A. Drebin · 1 shared paper, 2025 · strength 0.20
  18. Ethan S. Agritelley · 1 shared paper, 2025 · strength 0.20
  19. Diane L. Reidy‐Lagunes · 1 shared paper, 2025 · strength 0.20
  20. Peter J. Allen · 1 shared paper, 2025 · strength 0.20
  21. William R. Jarnagin · 1 shared paper, 2025 · strength 0.20
  22. T. Peter Kingham · 1 shared paper, 2025 · strength 0.20
  23. Alice Chia-Chi Wei · 1 shared paper, 2025 · strength 0.20
  24. Alex B. Blair · 1 shared paper, 2025 · strength 0.20
  25. Julie Ann Sosa · 2 shared papers, 2016–2017 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.